Nevro announces presentation of two abstracts for PDN and NSBP

Nevro announced that two abstracts for Painful Diabetic Neuropathy, or PDN, and Non-Surgical Back Pain, or NSBP, were accepted for podium presentations at the 2023 North American Neuromodulation Society Annual Meeting, and will be presented during the late-breaking plenary sessions on January 13-14, 2023 in Las Vegas, NV. A total of 18 abstracts covering Nevro’s proprietary 10 kHz Therapy(TM) were accepted for presentation at NANS 2023, including two late-breaking presentations, seven podium presentations and nine posters. Key presentations are highlighted below. Nevro’s PDN data presentation will highlight complete 24-month follow-up results for pain relief and improved neurological function. Nevro’s SENZA-PDN trial is the largest, Level 1 randomized controlled trial of spinal cord stimulation treatment studying PDN completed thus far with 216 randomized subjects. Results will be presented by Erika A. Petersen, MD, from the University of Arkansas for Medical Sciences, on January 14, 2023, during the E3 Session: Critical Updates in Neuromodulation. A second PDN data presentation will feature the results showing improvement in multiple quality of life metrics with 10 kHz Therapy. Results will also be presented by Erika A. Petersen, on January 13, 2023 during the E1 Session: APP. Nevro’s NSBP data presentation will feature 24-month outcomes from its SENZA-NSRBP RCT investigating 10 kHz Therapy for treating non-surgical refractory back pain, with 159 randomized participants from 15 study centers. Results will be presented by Leonardo Kapural, from Carolinas Pain Institute, Winston-Salem, NC, on January 13, 2023, during the Plenary Session II: Late-Breaking Abstracts. A second NSBP data presentation will feature the important improvements in non-pain outcomes such as sleep, mental health and function experienced by patients treated with 10 kHz Therapy in the SENZA-NSRBP RCT. Results will be presented by Jessica Jameson, MD, FASA, from Axis Spine Center, Coeur d’Alene, ID on January 13, 2023, from during the D1 Session: Spine.